RUMS Review Vol. VIII Issue I - January 2023

News in Brief
By Nilay Sah
Lecanemab heralds new dawn for
Alzheimer Drug Research
Promising results from a
trial testing Lecanemab
have marked a turning point
in Alzheimer drug
development – a field that
has been riddled for 30
years with disappointment.
Nurses vote to strike for first
time in UK History
100,000 nursing staff are
set to strike with over 40
NHS trusts in favour of
walkouts. The Royal College
of Nursing are calling for a
China lifts tight Zero-
Covid measures
China’s three yearlong set
of stringent ‘dynamic’ zerocovid
strategy has finally
been relaxed following
landmark protests, the likes
not seen since Tiananmen
Square 1989. Mandatory
The first disease altering
drug of its kind, Lecanemab
antibodies target and
destroy amyloid plaques
that cause Alzheimer’s,
paving the way for exciting
future drug development.
19.2% pay increase amidst a
nationwide shortage of over
50,000 nurses, with 34,000
leaving the service last year
alone.
PCRs to strictly enforced
quarantine camps have
been scrapped while the
country grapples with the
largest wave of infections
since the start of the
pandemic.
Medical News
12